Vancouver, British Columbia – TheNewswire – October 22, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announce the first shipping container of NATERA Plant Based Foods has arrived from Australia. In anticipation of demand, a second shipping container has been processed and is on route toContinue reading “Naturally Splendid Receives First Container of NATERA Plant Based Foods”
Tag Archives: Investing in Naturally Splendid
Naturally Splendid Responds to Health Canada’s Information Request Notice
Vancouver, British Columbia – TheNewswire – October 16, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) has responded through their joint venture Plasm Pharmaceutical (“Plasm”) to Health Canada’s Information Request Notice (“IRN”). The questions as posed by Health Canada are considered a formality as Plasm Pharmaceutical, continues to prepare for aContinue reading “Naturally Splendid Responds to Health Canada’s Information Request Notice”
Naturally Splendid Launches New Corporate Website and Provides Strategic Update
VANCOUVER, British Columbia – TheNewswire – October 5, 2020 — Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce the new Corporate website is now live at www.naturallysplendid.com. In addition to the new Corporate website, the Company will be systematically updating the individual Company brand websites to enhance consumer experience and improve the e-commerce procedure andContinue reading “Naturally Splendid Launches New Corporate Website and Provides Strategic Update”
Naturally Splendid Closes Private Placement, Secures Laboratory Facility
— Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce that it has closed its non-brokered private placement financing for a total of 15,887,503 units (the “Units”) at $0.06 per Unit, for total gross proceeds of $1,053,250 (the “Offering”). Due to oversubscribed demand, the private placement financing was increased from 14,166,667 Units to 17,554,167.Continue reading “Naturally Splendid Closes Private Placement, Secures Laboratory Facility”
Naturally Splendid Announces Biologic Definitive Agreement and Private Placement
“We continue to make progress on several fronts including significant steps towards beginning a phase 2 clinical trial for a potential COVID-19 treatment.” Founder & CEO Craig Goodwin Vancouver, British Columbia – The Newswire – September 2, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announceContinue reading “Naturally Splendid Announces Biologic Definitive Agreement and Private Placement”
Health Canada Requests Protocol Details of COVID-19 Phase 2 Clinical Trial
– TheNewswire – August 10, 2020 — Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) advises that subsequent to Heath Canada issuing a No Objection Letter, they have requested specific protocol details regarding the Clinical Trial Application for CavaltinibTM, the target drug of the proposed joint venture with Biologic Pharmaceutical Research, before the trial may commence.Continue reading “Health Canada Requests Protocol Details of COVID-19 Phase 2 Clinical Trial”
Health Canada Grants No Objection Letter to Proceed with COVID-19 Phase 2 Clinical Trial
– July 29, 2020 — Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce that the Company’s phase 2 clinical trial, as per its proposed joint venture with Biologic Pharmamedical Research for Cavaltinib(TM) (See Company news release, May 15, 2020.), has been approved for a COVID-19 clinical trial by Health Canada. The NoContinue reading “Health Canada Grants No Objection Letter to Proceed with COVID-19 Phase 2 Clinical Trial”
Naturally Splendid Passes Facility Audit for Annual SQF Certification
— Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce the Company’s wholly owned division, Prosnack Natural Foods (“Prosnack”) has passed it’s annual audit of its Safe Quality Food certified food manufacturing facility. The Safe Quality Food (SQF) Program is a rigorous food safety and quality program that is known by retailers, brand owners, andContinue reading “Naturally Splendid Passes Facility Audit for Annual SQF Certification”
Health Canada Requests Clinical Trial Protocol Details
– June 30, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to provide the following update in regards to the Clinical Trial Application (CTA) to Health Canada submitted May 17, 2020 as a treatment for Covid-19 with the target drug, Cavaltinib(TM). The Company continues to navigate the fast track CTA process withContinue reading “Health Canada Requests Clinical Trial Protocol Details”
